Transcranial magnetic stimulation for the treatment of methamphetamine/cocaine use disorder (CTN-0108). 9/21/2020-7/17/2023. N01DA-19-2250. Task order 75N95020F00007 (TO18).
Ended Awarded Last action
- Contract number
- 75N95020F00007
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $806,041
Award facts
- Opportunity
-
- 75N95020F00007 Solicitation number
- Contract value 100% obligated
- $806,041.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$24,878 | |
| Original award | $830,919 |
About this award
This is a $806,041.38 cost-plus-fixed-fee task order awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA) for the "Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder (CTN-0108)" study. The task order, which has a period of performance from 9/21/2020 to 7/17/2023, is part of NIDA's "Data, Statistics, and Clinical Trial Support Center" major program. The Emmes Company, a for-profit limited liability company located in Rockville, MD, is a global clinical research organization that provides comprehensive research support services to federal agencies, particularly within the National Institutes of Health (NIH). This task order is not designated as a set-aside contract. The study involves the use of transcranial magnetic stimulation for the treatment of methamphetamine and cocaine use disorder.
Quick answers
Who was awarded contract 75N95020F00007?
75N95020F00007 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 21, 2020.
How much is contract 75N95020F00007 worth?
The government has obligated $806,041 on 75N95020F00007.
Is contract 75N95020F00007 an order under another contract?
Yes. 75N95020F00007 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95020F00007 competed?
The extent of competition for 75N95020F00007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award